Literature DB >> 2196964

Microionophoretic study with milacemide, a glycine precursor, on mammalian central nervous system cells.

J M Godfraind1.   

Abstract

1. The effect of milacemide, a glycine percursor known to increase gamma-aminobutyric acid (GABA) and glycine content in the brain, and to have anticonvulsant properties, was tested by ionophoresis on 247 neurones situated in the cerebral cortex and in deeper structures of cats and rats anaesthetized with urethane. 2. Virtually all the neurones, either firing spontaneously or exogenously driven by the excitatory amino acids, glutamate, N-methyl-D-aspartate (NMDA), kainate and quisqualate or by acetylcholine, were reversibly depressed in a dose-dependent fashion. The same depressant effect was observed in animals pretreated with the monoamine oxidase B inhibitor (IMAO-B) deprenyl which is known to reduce milacemide metabolism into glycinamide and glycine. Intravenous administration of milacemide (10 to 100 mg kg-1) also depressed the firing induced by glutamate, NMDA and acetylcholine. 3. When compared to GABA, milacemide was a weaker depressant. However, its effect could still be observed in the presence of the reversible GABAA antagonist, SR 95531, and thus milacemide is unlikely to act through GABA receptors. In addition, on cells unaffected by glycine, milacemide also had a depressant effect, and on cells inhibited by glycine, it was still capable of depressing cell firing during reversible blockade by strychnine of the glycine inhibitory action; thus milacemide is unlikely to act through glycine receptors. Simultaneous release of milacemide and GABA or of milacemide and glycine, did not show potentiation of the inhibitory amino acid action. However, the depressant effect of milacemide was additive with that of GABA and glycine. 4. No consistent depression of glutamate-induced firing was obtained by ionophoresis of glycinamide, the first metabolite of milacemide. 5. It is concluded that milacemide by itself is a depressant agent and that its depressant effect does not necessarily require its metabolism into glycine, or its stimulator effect on the production of GABA.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2196964      PMCID: PMC1917452          DOI: 10.1111/j.1476-5381.1990.tb12062.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  29 in total

Review 1.  Epilepsy and gamma-aminobutyric acid-mediated inhibition.

Authors:  B S Meldrum
Journal:  Int Rev Neurobiol       Date:  1975       Impact factor: 3.230

2.  Central actions of valproate sodium.

Authors:  M Schmutz; H R Olpe; W P Koella
Journal:  J Pharm Pharmacol       Date:  1979-06       Impact factor: 3.765

3.  Sodium valproate increases potassium conductance in Aplysia neurons.

Authors:  G E Slater; D Johnston
Journal:  Epilepsia       Date:  1978-08       Impact factor: 5.864

4.  The action of glycine on cortical neurones.

Authors:  J S Kelly; K Krnjević
Journal:  Exp Brain Res       Date:  1969       Impact factor: 1.972

5.  2-Amino-5-phosphonovalerate (2APV), a potent and selective antagonist of amino acid-induced and synaptic excitation.

Authors:  J Davies; A A Francis; A W Jones; J C Watkins
Journal:  Neurosci Lett       Date:  1981-01-01       Impact factor: 3.046

6.  Sodium valproate enhances responses to GABA receptor activation only at high concentrations.

Authors:  N L Harrison; M A Simmonds
Journal:  Brain Res       Date:  1982-10-28       Impact factor: 3.252

7.  Substantia nigra: site of anticonvulsant activity mediated by gamma-aminobutyric acid.

Authors:  M J Iadarola; K Gale
Journal:  Science       Date:  1982-12-17       Impact factor: 47.728

8.  Acetylcholine and somatically evoked inhibition on perigeniculate neurones in the cat.

Authors:  J M Godfraind
Journal:  Br J Pharmacol       Date:  1978-06       Impact factor: 8.739

9.  On the action of the anticonvulsant 5,5-diphenylhydantoin and the convulsant picrotoxin in crayfish stretch receptor.

Authors:  C C Aickin; R A Deisz; H D Lux
Journal:  J Physiol       Date:  1981-06       Impact factor: 5.182

10.  The inhibitory action of glycine on rat cortical neurons.

Authors:  G Bernardi; E Cherubini; M G Marciani; P Stanzione
Journal:  Neurosci Lett       Date:  1979-05       Impact factor: 3.046

View more
  1 in total

1.  Effect of milacemide on extracellular and tissue concentrations of dopamine and 5-hydroxytryptamine in rat frontal cortex.

Authors:  J Semba; M Doheny; P N Patsalos; G Sarna; G Curzon
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.